Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

California congressman proposes testing automatic enrollment in ACA plans

In states that choose to utilize federal grants for the pilot program, those who don’t want coverage would have to actively opt out of plans within 60 days.

Thumbnail

Online physician reviews take communication, bedside manner into consideration

Online physician reviews are largely based on patients' experiences with communication and bedside manner, according to a study published in the May issue of Plastic and Reconstructive Surgery.

Thumbnail

Hospital M&A activity expected to continue brisk pace in 2018

If the first quarter of the year is any indication, the frantic pace of mergers and acquisitions (M&A) among hospitals won’t be slowing down in 2018. Thirty transactions were announced between January 1 and March 31, an 11 percent increase over the same period in 2017, according to Kaufman Hall.

Amazon already tried—and failed—to disrupt pharmaceuticals

In 1999, Amazon bought a 46 percent stake in Drugstore.com and began marketing its products on the Amazon site. Once hailed as “a likely gold mine,” the venture never turned a profit after running into problems with regulations, logistics and the existing pharmacy benefit managers that already dominated the market.

Thumbnail

Getting better with age: Older surgeons have lower patient mortality rates

The older a surgeon gets, the lower the patient mortality rate, with female surgeons in their 50s having the lowest rates overall, according to research led by Yusuke Tsugawa, MD, MPH, PhD, assistant professor at the University of California, Los Angeles.

Thumbnail

Hospitals largely supportive of 2019 IPPS proposed rule

Fewer quality measures, a shorter reporting period for Meaningful Use requirements and an increase in uncompensated rate payments were all positives in the eyes of hospitals in their initial reaction to the proposed 2019 Medicare Inpatient Prospective Payment System (IPPS) rule.

Thumbnail

Mind matters: 8 ethical questions about experimenting with human brain tissue

Lab-created consciousness, especially resulting from testing human brain tissue, sounds like the plot for the newest binge-worthy TV show, but it’s a matter worth consideration from an ethical perspective, according to some experts. A group of 17 researchers examined issues that may arise as scientists get closer to replicating human brain functions.

Thumbnail

mHealth app for clinical decision support improves diagnosis time, test ordering

Mobile health (mHealth) applications for clinical decision support could improve physicians' test ordering and diagnosis decisions, according to a study published April 20 in the Journal of Informatics in Health and Biomedicine.

Displaying 3593 - 3600 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup